Radiotherapy plus Cisplatin or Cetuximab in low-risk human papillomavirus positive oropharyngeal cancer (De-ESCALaTE HPV): An open-label randomised controlled phase 3 trial
Key publications on oropharyngeal cancer
Chairpersons :
Sudeep Sarkar, Mehul Bhansali, Jyoti Dabholkar
Reviewer :
Vikas Talreja